Clinical trial

Vitamin D Metabolism in Patients With Endocrine Disorders

NCT04844164

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Cholecalciferol 15000 UNT/ML Oral Solution Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Vitamin D Metabolism in Patients With Endocrine Disorders

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-16

PhasePHASE1

Conditions

Pituitary ACTH Hypersecretionunresolved

Acromegalyverified · MONDO: acromegaly

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Primary Hyperparathyroidismverified · MONDO: primary hyperparathyroidism

Interventions

Cholecalciferol 15000 UNT/ML Oral SolutionDRUG

Sponsors & collaborators

Endocrinology Research Centre, Moscowlead sponsor

Russian Science Foundationcollaborator

Mapped research locations

MoscowRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04844164 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.